Molecules · 2014 · 49 citations · 36 references
Life SciencesMedicinal ChemistryPharmacologyBiochemical PharmacologyCellular MetabolismMetabolismAdipose TissueLipid MetabolismLipid MobilizationMetabolic SignalingTriacylglycerol MetabolismTriglyceride MetabolismAdipocyte BiologyAdipocyte Lipid MetabolismAdipocyte MetabolismCyclic Adenosine Monophosphate PathwayCyclic Adenosine Monophosphate SignalingGlycerol MetabolismLipid AccumulationLipid Metabolism Effects
Obesity and its related disorders have become leading metabolic diseases. In the present study, we used 3T3-L1 adipocytes to investigate the anti-obesity activity of hispidin and two related compounds that were isolated from Alpinia zerumbet (alpinia) rhizomes. The results showed that hispidin, dihydro-5,6-dehydrokawain (DDK), and 5,6-dehydrokawain (DK) have promising anti-obesity properties. In particular, all three compounds significantly increased intracellular cyclic adenosine monophosphate (cAMP) concentrations by 81.2% ± 0.06%, 67.0% ± 1.62%, and 56.9% ± 0.19%, respectively. Hispidin also stimulated glycerol release by 276.4% ± 0.8% and inhibited lipid accumulation by 47.8% ± 0.16%. Hispidin and DDK decreased intracellular triglyceride content by 79.5% ± 1.37% and 70.2% ± 1.4%, respectively, and all three compounds inhibited glycerol-3-phosphate dehydrogenase (GPDH) and pancreatic lipase, with hispidin and DDK being the most potent inhibitors. Finally, none of the three compounds reduced 3T3-L1 adipocyte viability. These results highlight the potential for developing hispidin and its derivatives as anti-obesity compounds.
36
Yoko Akazome, Toshihiko Shoji, Atsuko Yamaguchi et al. · Journal of Agricultural and Food Chemistry · 2007 · 329 citations